Vir Biotechnology Inc. (VIR)
NASDAQ · Healthcare
Vir Biotechnology Inc. Shareholder Equity 2017–2025
Vir Biotechnology Inc. annual shareholder equity history from 2018 to 2025. Shareholder equity represents the net worth of a company, calculated as total assets minus total liabilities.
- Vir Biotechnology Inc. shareholder equity as of December 31, 2025: 765.3M, a 33.48% decrease year-over-year.
- Vir Biotechnology Inc. shareholder equity for 2025 were 765.3M, a 33.48% decrease from 2024.
- Vir Biotechnology Inc. shareholder equity for 2024 were 1.15B, a 27.66% decrease from 2023.
- Vir Biotechnology Inc. shareholder equity for 2023 were 1.59B, a 23.47% decrease from 2022.
- Vir Biotechnology Inc. shareholder equity for 2022 were 2.08B.
Shareholder Equity
ANNUAL · $B
YEAR-OVER-YEAR GROWTH · %
| Vir Biotechnology Inc. Annual Shareholder Equity (Millions of US $) | |
|---|---|
| 2025 | $765 |
| 2024 | $1,150 |
| 2023 | $1,590 |
| 2022 | $2,078 |
| 2021 | $1,432 |
| 2020 | $717 |
| 2019 | $424 |
| 2018 | $-179 |
Vir Biotechnology Inc. Shareholder Equity — FAQ
Vir Biotechnology Inc. (VIR) shareholder equity over the last 9 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see VIR's shareholder equity history?
The chart and table above show Vir Biotechnology Inc.'s shareholder equity by year and by quarter, including the growth rate.